Literature DB >> 25461194

Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.

Robert E Featherstone1, Rick Shin2, Jeffrey H Kogan2, Yuling Liang1, Mitsuyuki Matsumoto2, Steven J Siegel3.   

Abstract

Reductions in glutamate function are regarded as an important contributory factor in schizophrenia. However, there is a paucity of animal models characterized by developmental and sustained reductions in glutamate function. Pharmacological models using NMDA antagonists have been widely used but these typically produce only transient changes in behavior and brain function. Likewise, mice with homozygous constitutive reductions in glutamate receptor expression show stable brain and behavioral changes, but many of these phenotypes are more severe than the human disease. The current study examines a variety of schizophrenia-related EEG measures in mice with a heterozygous alteration of the NMDA receptor NR1 subunit gene (NR1) that is known to result in reduced NR1 receptor expression in the homozygous mouse (NR1-/-). (NR1+/-) mice showed a 30% reduction in NR1 receptor expression and were reared after weaning in either group or isolated conditions. Outcome measures include the response to paired white noise stimuli, escalating inter-stimulus intervals (ISIs) and deviance-related mismatch negativity (MMN). In contrast to what has been reported in (NR1-/-) mice and mice treated with NMDA antagonists, (NR1+/-) mice showed no change on obligatory Event Related Potential (ERP) measures including the murine P50 and N100 equivalents (P20 and N40), or measures of baseline or evoked gamma power. Alternatively, (NR1+/-) mice showed a marked reduction in response to a deviant auditory tone during MMN task. Data suggest that EEG response to deviant, rather than static, stimuli may be more sensitive for detecting subtle changes in glutamate function. Deficits in these heterozygous NR1 knockdown mice are consistent with data demonstrating MMN deficits among family members of schizophrenia patients and among prodromal patients. Therefore, the current study suggests that (NR1+/-) mice may be among the most sensitive models for increased vulnerability to schizophrenia.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  EEG; Mismatch negativity; Mouse; NMDA; Schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25461194     DOI: 10.1016/j.nbd.2014.10.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  19 in total

1.  Somatostatin Interneurons Control a Key Component of Mismatch Negativity in Mouse Visual Cortex.

Authors:  Jordan P Hamm; Rafael Yuste
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?

Authors:  Maju Mathew Koola
Journal:  Mol Neuropsychiatry       Date:  2018-06-07

3.  Parvalbumin Cell Ablation of NMDA-R1 Leads to Altered Phase, But Not Amplitude, of Gamma-Band Cross-Frequency Coupling.

Authors:  Russell G Port; Jeffrey I Berman; Song Liu; Robert E Featherstone; Timothy P L Roberts; Steven J Siegel
Journal:  Brain Connect       Date:  2019-03-15

4.  Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.

Authors:  W C Hochberger; Y B Joshi; W Zhang; M L Thomas; D L Braff; N R Swerdlow; G A Light
Journal:  Int J Psychophysiol       Date:  2018-12-23       Impact factor: 2.997

Review 5.  Glutamate and GABA imbalance following traumatic brain injury.

Authors:  Réjean M Guerriero; Christopher C Giza; Alexander Rotenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

6.  Altered Cortical Ensembles in Mouse Models of Schizophrenia.

Authors:  Jordan P Hamm; Darcy S Peterka; Joseph A Gogos; Rafael Yuste
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

Review 7.  The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

Authors:  Peijun Ju; Donghong Cui
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

8.  Identification of TAAR5 Agonist Activity of Alpha-NETA and Its Effect on Mismatch Negativity Amplitude in Awake Rats.

Authors:  Aleksander A Aleksandrov; Veronika M Knyazeva; Anna B Volnova; Elena S Dmitrieva; Olga Korenkova; Stefano Espinoza; Andrey Gerasimov; Raul R Gainetdinov
Journal:  Neurotox Res       Date:  2018-05-01       Impact factor: 3.911

9.  GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.

Authors:  D Sinclair; R Featherstone; M Naschek; J Nam; A Du; S Wright; K Pance; O Melnychenko; R Weger; S Akuzawa; M Matsumoto; S J Siegel
Journal:  eNeuro       Date:  2017-03-01

Review 10.  The Neuronal Basis of Predictive Coding Along the Auditory Pathway: From the Subcortical Roots to Cortical Deviance Detection.

Authors:  Guillermo V Carbajal; Manuel S Malmierca
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.